Form 4: Bluebird Bio Executive Thomas Klima Sells Shares to Cover Tax Obligations

Thomas Klima, Chief Commercial & Operating Officer of bluebird bio, sold 122 shares of common stock on February 3, 2025, to cover tax withholding obligations.

Summary

• Thomas J. Klima, Chief Commercial & Operating Officer of bluebird bio, Inc., reported the sale of 122 shares of common stock on February 3, 2025.
• The shares were sold at an average weighted price of $7.3925, with individual prices ranging from $7.27 to $7.55.
• The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units.
• Following the transaction, Klima directly owns 8,378 shares of bluebird bio, Inc.
• The reporting person has a Power of Attorney designating Andrew Obenshain, Joseph Vittiglio, and Sydney Gaylin as attorneys-in-fact.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions. It doesn't convey any strong positive or negative sentiment about the company's performance or prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, which is common for executives at publicly traded companies. The sale appears to be related to covering tax obligations, a typical reason for such transactions.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the reason for the sale (tax obligations) is generally understood and accepted.

Key Dates